Literature DB >> 19913614

The human alpha11 integrin promoter drives fibroblast-restricted expression in vivo and is regulated by TGF-beta1 in a Smad- and Sp1-dependent manner.

Ning Lu1, Sergio Carracedo, Jonna Ranta, Rainer Heuchel, Raija Soininen, Donald Gullberg.   

Abstract

Integrin alpha11beta1 is expressed by ectomesenchymally- and mesodermally-derived fibroblasts and is the major collagen receptor on embryonic fibroblasts. We have previously characterized a 3kb human alpha11 promoter region in vitro. In the current study we generated promoter-LacZ reporter transgenic mice to examine the ability of the 3kb alpha11 promoter to drive tissue-specific expression also in vivo. Our data show that the 3 kb alpha11 promoter contains most of the regulatory elements that direct ectomesenchymal and mesodermal fibroblast-specific expression. Not much is known about integrin alpha11 regulation by TGF-beta family members and the potential role of alpha11 in TGF-beta1 driven processes such as fibrosis and wound contraction. In the current study we show that TGF-beta1 induces alpha11 transcription in the fibrosarcoma cell line HT1080 as well as in primary fibroblasts. Co-transfection of an expression plasmid encoding constitutively active ALK5 together with alpha11 promoter-luciferase reporter constructs demonstrated that TGF-beta1 responsive elements are located within the 3kb alpha11 promoter. Serial deletions located TGF-beta1 responsiveness to the proximal promoter (nt -176/+25) as well as to the region extending to nt -330. Transfection and expression of the inhibitory Smad7 in the cells attenuated the TGF-beta1-dependent alpha11 induction both at the RNA and the protein level. Mutation and deletion analyses identified a Smad-binding element, SBE2 (nt -182/-176), as an important Smad3-binding site in this part of the promoter. Further analyses suggested that the Sp1-binding site SBS1 (nt -140/-134) takes part in the responsiveness to TGF-beta1 in a Smad2-dependent manner. In summary, our data confirm that 3kb of the alpha11 promoter is efficient in driving tissue-specific expression in vivo. We also demonstrate that this promoter confers TGF-beta1 responsiveness which appears to rely on both a Smad-binding element at nt -182/-176 and a Sp1-binding site at nt -140/-134. Our data furthermore indicate that additional elements needed for TGF-beta1 responsiveness are located upstream in the -2962/-330 promoter region. Copyright 2009 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913614     DOI: 10.1016/j.matbio.2009.11.003

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  16 in total

1.  The fibroblast integrin alpha11beta1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation.

Authors:  Sergio Carracedo; Ning Lu; Svetlana N Popova; Roland Jonsson; Beate Eckes; Donald Gullberg
Journal:  J Biol Chem       Date:  2010-02-02       Impact factor: 5.157

2.  Transcription of the transforming growth factor beta activating integrin beta8 subunit is regulated by SP3, AP-1, and the p38 pathway.

Authors:  Jennifer A Markovics; Jun Araya; Stephanie Cambier; David Jablons; Arthur Hill; Paul J Wolters; Stephen L Nishimura
Journal:  J Biol Chem       Date:  2010-06-02       Impact factor: 5.157

3.  Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer.

Authors:  Roya Navab; Dan Strumpf; Bizhan Bandarchi; Chang-Qi Zhu; Melania Pintilie; Varune Rohan Ramnarine; Emin Ibrahimov; Nikolina Radulovich; Lisa Leung; Malgorzata Barczyk; Devang Panchal; Christine To; James J Yun; Sandy Der; Frances A Shepherd; Igor Jurisica; Ming-Sound Tsao
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-07       Impact factor: 11.205

4.  Matrix metalloproteinase (MMP)-19-deficient fibroblasts display a profibrotic phenotype.

Authors:  Paul Jara; Jazmin Calyeca; Yair Romero; Luis Plácido; Guoying Yu; Naftali Kaminski; Vilma Maldonado; José Cisneros; Moisés Selman; Annie Pardo
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-01-09       Impact factor: 5.464

Review 5.  Fibroblast Growth Factor 2 as an Antifibrotic: Antagonism of Myofibroblast Differentiation and Suppression of Pro-Fibrotic Gene Expression.

Authors:  David M Dolivo; Sara A Larson; Tanja Dominko
Journal:  Cytokine Growth Factor Rev       Date:  2017-09-23       Impact factor: 7.638

6.  The small-molecule protein ligand interface stabiliser E7820 induces differential cell line specific responses of integrin α2 expression.

Authors:  Michael David Hülskamp; Daniel Kronenberg; Richard Stange
Journal:  BMC Cancer       Date:  2021-05-18       Impact factor: 4.430

7.  Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer.

Authors:  R Navab; D Strumpf; C To; E Pasko; K S Kim; C J Park; J Hai; J Liu; J Jonkman; M Barczyk; B Bandarchi; Y H Wang; K Venkat; E Ibrahimov; N-A Pham; C Ng; N Radulovich; C-Q Zhu; M Pintilie; D Wang; A Lu; I Jurisica; G C Walker; D Gullberg; M-S Tsao
Journal:  Oncogene       Date:  2015-07-06       Impact factor: 9.867

Review 8.  Clinical Advancements in the Targeted Therapies against Liver Fibrosis.

Authors:  Ruchi Bansal; Beata Nagórniewicz; Jai Prakash
Journal:  Mediators Inflamm       Date:  2016-11-24       Impact factor: 4.711

9.  Release of tensile strain on engineered human tendon tissue disturbs cell adhesions, changes matrix architecture, and induces an inflammatory phenotype.

Authors:  Monika L Bayer; Peter Schjerling; Andreas Herchenhan; Cedric Zeltz; Katja M Heinemeier; Lise Christensen; Michael Krogsgaard; Donald Gullberg; Michael Kjaer
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

10.  Fibroblast α11β1 integrin regulates tensional homeostasis in fibroblast/A549 carcinoma heterospheroids.

Authors:  Ning Lu; Tine V Karlsen; Rolf K Reed; Marion Kusche-Gullberg; Donald Gullberg
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.